Pfizer Inc at Morgan Stanley Global Healthcare Conference Transcript
Great. Well, thanks for joining us, everybody. I'm Terence Flynn, the U.S. biopharma analyst here at Morgan Stanley, and we're very pleased to be hosting Pfizer today. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. Today from the company, we have Angela Hwang, who is CCO and President of the Biopharma segment at Pfizer; and Suneet Varma, who is Global Oncology and U.S. President, also within the Biopharma Group.
Thanks so much both for joining us today. Really appreciate the time.
Thank you.
Questions & Answers
I thought maybe to start off, a question we get a lot from investors is just the 6% revenue growth guidance that
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
